Ligand Pharma (LGND)
235.91
0.00 (0.00%)
Upcoming Events
Latest Headlines
Form 4 LIGAND PHARMACEUTICALS For: Jun 01 Filed by: Reardon Andrew
June 2, 2026 6:22 PM - SEC Filing
Form 4 LIGAND PHARMACEUTICALS For: May 27 Filed by: Espinoza Octavio
May 28, 2026 7:43 PM - SEC Filing
Ligand to Participate in June Investor Conferences
May 27, 2026 4:01 PM - Globe NewsWire
Form DEFA14A LIGAND PHARMACEUTICALS
May 18, 2026 9:03 AM - SEC Filing
Form 8-K LIGAND PHARMACEUTICALS For: May 16
May 18, 2026 9:02 AM - SEC Filing
Form 4 LIGAND PHARMACEUTICALS For: May 01 Filed by: KOZARICH JOHN W
May 14, 2026 9:09 PM - SEC Filing
Form 144 LIGAND PHARMACEUTICALS Filed by: KOZARICH JOHN W
May 13, 2026 4:09 PM - SEC Filing
Form 144 LIGAND PHARMACEUTICALS Filed by: KOZARICH JOHN W
May 12, 2026 5:45 PM - SEC Filing
Orchestra BioMed Reports First Quarter 2026 Financial Results and Highlights Recent Business Updates
May 12, 2026 4:18 PM - Globe NewsWire
Form 10-Q LIGAND PHARMACEUTICALS For: Mar 31
May 8, 2026 4:15 PM - SEC Filing
Ligand Pharma (LGND) PT Raised to $262 at RBC Capital
May 8, 2026 7:34 AM - StreetInsider
Ligand Pharma (LGND) Misses Q1 EPS by 21c
May 7, 2026 7:42 AM - StreetInsider
Form 8-K LIGAND PHARMACEUTICALS For: May 07
May 7, 2026 7:04 AM - SEC Filing
Ligand Reports First Quarter 2026 Financial Results
May 7, 2026 7:01 AM - Globe NewsWire
Orchestra BioMed receives $15 million from Ligand under financing agreement
May 6, 2026 8:01 AM - StreetInsider
Orchestra BioMed Receives $15 Million Investment from Ligand Under Previously Announced Strategic Financing Agreement
May 6, 2026 8:01 AM - Globe NewsWire
Ligand to Participate in May Investor Conferences
May 5, 2026 4:01 PM - Globe NewsWire
Form 4 LIGAND PHARMACEUTICALS For: May 01 Filed by: Reardon Andrew
May 4, 2026 8:20 PM - SEC Filing
Oppenheimer Assumes Ligand Pharma (LGND) at Outperform
May 4, 2026 8:17 AM - StreetInsider
Form 144 LIGAND PHARMACEUTICALS Filed by: KOZARICH JOHN W
May 1, 2026 4:17 PM - SEC Filing
Form SCHEDULE 13G LIGAND PHARMACEUTICALS Filed by: VANGUARD PORTFOLIO MANAGEMENT LLC
May 1, 2026 9:22 AM - SEC Filing
Form SCHEDULE 13G LIGAND PHARMACEUTICALS Filed by: VANGUARD CAPITAL MANAGEMENT LLC
May 1, 2026 9:12 AM - SEC Filing
Form 8-K LIGAND PHARMACEUTICALS For: Apr 24
April 30, 2026 4:41 PM - SEC Filing
Ligand Pharma (LGND) PT Raised to $289 at H.C. Wainwright
April 30, 2026 6:51 AM - StreetInsider
Ligand Pharma (LGND) PT Raised to $330 at Craig-Hallum
April 28, 2026 11:03 AM - StreetInsider
Form DEFA14A LIGAND PHARMACEUTICALS
April 28, 2026 6:07 AM - SEC Filing
Ligand Pharma (LGND) PT Raised to $252 at RBC Capital
April 28, 2026 5:06 AM - StreetInsider
Ligand Pharma (LGND) PT Raised to $260 at BofA Securities
April 27, 2026 2:55 PM - StreetInsider
Ligand Pharma (LGND) PT Raised to $255 at Stifel
April 27, 2026 1:56 PM - StreetInsider
Form DEFA14A LIGAND PHARMACEUTICALS
April 27, 2026 9:41 AM - SEC Filing
Form 8-K LIGAND PHARMACEUTICALS For: Apr 27
April 27, 2026 9:30 AM - SEC Filing
Ligand to acquire XOMA Royalty for $739 million in cash deal
April 27, 2026 7:01 AM - StreetInsider
Ligand to acquire XOMA Royalty for $739 million in cash deal
April 27, 2026 7:00 AM - StreetInsider
Ligand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand’s Position as a Leading Biopharma Royalty Aggregator
April 27, 2026 7:00 AM - Globe NewsWire
Ligand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand’s Position as a Leading Biopharma Royalty Aggregator
April 27, 2026 7:00 AM - Globe NewsWire
Ligand Pharma (LGND) to buy Xoma for ~$740M - WSJ
April 27, 2026 6:16 AM - StreetInsider
Ligand to Report First Quarter 2026 Financial Results on May 7, 2026
April 22, 2026 7:01 AM - Globe NewsWire
Form ARS LIGAND PHARMACEUTICALS For: Dec 31
April 21, 2026 4:05 PM - SEC Filing
Form DEFA14A LIGAND PHARMACEUTICALS
April 21, 2026 4:03 PM - SEC Filing
Form DEF 14A LIGAND PHARMACEUTICALS For: Dec 31
April 21, 2026 4:03 PM - SEC Filing
Ligand Pharma (LGND) PT Raised to $282 at Citi
April 14, 2026 12:51 PM - StreetInsider
Ligand Pharma (LGND) PT Raised to $243 at H.C. Wainwright
April 14, 2026 10:37 AM - StreetInsider
Ligand Pharma (LGND) PT Raised to $250 at BofA Securities
April 14, 2026 9:11 AM - StreetInsider
FDA approves FILSPARI for rare kidney disease FSGS
April 14, 2026 7:00 AM - StreetInsider
Ligand Partner Travere Therapeutics Receives Full FDA Approval for FILSPARI® (sparsentan) in FSGS
April 14, 2026 7:00 AM - Globe NewsWire
Form 4 LIGAND PHARMACEUTICALS For: Apr 01 Filed by: KOZARICH JOHN W
April 2, 2026 7:44 PM - SEC Filing
Form 4 LIGAND PHARMACEUTICALS For: Apr 01 Filed by: Reardon Andrew
April 2, 2026 6:57 PM - SEC Filing
Form 144 LIGAND PHARMACEUTICALS Filed by: KOZARICH JOHN W
April 1, 2026 4:11 PM - SEC Filing
Form 4 LIGAND PHARMACEUTICALS For: Mar 06 Filed by: LAMATTINA JOHN L
March 31, 2026 5:53 PM - SEC Filing
Form 4 LIGAND PHARMACEUTICALS For: Mar 02 Filed by: Espinoza Octavio
March 27, 2026 9:21 PM - SEC Filing
Form 4 LIGAND PHARMACEUTICALS For: Mar 02 Filed by: Davis Todd C
March 27, 2026 8:33 PM - SEC Filing
Form 4 LIGAND PHARMACEUTICALS For: Mar 02 Filed by: Reardon Andrew
March 27, 2026 8:17 PM - SEC Filing
Form SCHEDULE 13G/A LIGAND PHARMACEUTICALS Filed by: VANGUARD GROUP INC
March 27, 2026 10:33 AM - SEC Filing
Ligand Advances Strategic Growth with Expanded and Strengthened Business Development Team
March 26, 2026 7:01 AM - Globe NewsWire
Form 4 LIGAND PHARMACEUTICALS For: Mar 23 Filed by: Sabba Stephen L
March 25, 2026 11:14 AM - SEC Filing
Citi Adjusts Catalyst Call List
March 24, 2026 5:03 AM - StreetInsider
Ligand Pharma (LGND) PT Raised to $276 at Citi
March 24, 2026 5:00 AM - StreetInsider
Form 144 LIGAND PHARMACEUTICALS Filed by: Sabba Stephen L
March 23, 2026 4:04 PM - SEC Filing
Form 4 LIGAND PHARMACEUTICALS For: Mar 11 Filed by: Espinoza Octavio
March 19, 2026 11:33 AM - SEC Filing
Form 4 LIGAND PHARMACEUTICALS For: Mar 11 Filed by: Espinoza Octavio
March 13, 2026 7:30 PM - SEC Filing
Form 144 LIGAND PHARMACEUTICALS Filed by: Espinoza Octavio
March 11, 2026 4:42 PM - SEC Filing
BofA Securities Starts Ligand Pharma (LGND) at Buy
March 11, 2026 6:03 AM - StreetInsider
Full Article List
